期刊文献+
共找到5篇文章
< 1 >
每页显示 20 50 100
Meranzin Hydrate Improves Depression-Like Behaviors and Hypomotility via Ghrelin and Neurocircuitry 被引量:1
1
作者 LIU Ya-lin XU Jian-jun +7 位作者 HAN Lin-ran LIU Xiang-fei LIN Mu-hai WANG Yun XIAO Zhe HUANG Yun-ke REN Ping HUANG Xi 《Chinese Journal of Integrative Medicine》 SCIE CAS CSCD 2023年第6期490-499,共10页
Objective To investigate whether meranzin hydrate(MH)can alleviate depression-like behavior and hypomotility similar to Chaihu Shugan Powder(CSP),and further explore the potential common mechanisms.Methods Totally 120... Objective To investigate whether meranzin hydrate(MH)can alleviate depression-like behavior and hypomotility similar to Chaihu Shugan Powder(CSP),and further explore the potential common mechanisms.Methods Totally 120 Spraque-Dawley rats were randomly divided into 5–8 groups including sham,vehicle,fluoxetine(20 mg/kg),mosapride(10 mg/kg),CSP(30 g/kg),MH(9.18 mg/kg),[D-Lys3]-GHRP-6(Dlys,0.5 mg/kg),and MH+Dlys groups by a random number table,8 rats in each group.And 32 mice were randomly divided into wild-type,MH(18 mg/kg),growth hormone secretagogue receptor-knockout(GHSR-KO),and GHSR+MH groups,8 mice in each group.The forced swimming test(FST),open field test(OFT),tail suspension test(TST),gastric emptying(GE)test,and intestinal transit(IT)test were used to assess antidepressant and prokinetic(AP)effects after drug single administration for 30 min with absorbable identification in rats and mice,respectively.The protein expression levels of brain-derived neurotrophic factor(BDNF)and phosphorylated mammalian target of rapamycin(p-mTOR)in the hippocampus of rats were evaluated by Western blot.The differences in functional brain changes were determined via 7.0 T functional magnetic resonance imaging-blood oxygen level-dependent(fMRI-BOLD).Results MH treatment improved depression-like behavior(FST,OFT)and hypomotility(GE,IT)in the acute forced swimming(FS)rats(all P<0.05),and the effects are similar to the parent formula CSP.The ghrelin antagonist[D-Lys3]-GHRP-6 inhibited the effect of MH on FST and GE(P<0.05).Similarly,MH treatment also alleviated depression-like behavior(FST,TST)in the wild-type mice,however,no effects were found in the GHSR KO mice.Additionally,administration of MH significantly stimulated BDNF and p-mTOR protein expressions in the hippocampus(both P<0.01),which were also prevented by[D-Lys3]-GHRP-6(P<0.01).Besides,3 main BOLD foci following acute FS rats implicated activity in hippocampus—thalamus—basal ganglia(HTB)circuits.The[D-Lys3]-GHRP-6 synchronously inhibited BOLD HTB foci.As expected,prokinetic mosapride only had effects on the thalamus and basal ganglia,but not on the hippocampus.Within the HTB,the hippocampus is implicated in depression and FD.Conclusions MH accounts for part of AP effects of parent formula CSP in acute FS rats,mainly via ghrelin-related shared regulation coupled to BOLD signals in brain areas.This novel functionally connection of HTB following acute stress,treatment,and regulation highlights anti-depression unified theory. 展开更多
关键词 Chinese medicine Gan(Liver)governing freeflow of qi COMORBIDITY depression hypomotility GHRELIN blood oxygen level-dependent
原文传递
Ineffective esophageal motility is associated with acute rejection after lung transplantation independent of gastroesophageal reflux
2
作者 Wai-Kit Lo Brent Hiramoto +2 位作者 Hilary J Goldberg Nirmal Sharma Walter W Chan 《World Journal of Gastroenterology》 SCIE CAS 2023年第21期3292-3301,共10页
BACKGROUND Gastroesophageal reflux is associated with poorer outcomes after lung transplant,likely through recurrent aspiration and allograft injury.Although prior studies have demonstrated a relationship between impe... BACKGROUND Gastroesophageal reflux is associated with poorer outcomes after lung transplant,likely through recurrent aspiration and allograft injury.Although prior studies have demonstrated a relationship between impedance-pH results and transplant outcomes,the role of esophageal manometry in the assessment of lung transplant patients remains debated,and the impact of esophageal dysmotility on transplant outcomes is unclear.Of particular interest is ineffective esophageal motility(IEM)and its associated impact on esophageal clearance.AIM To assess the relationship between pre-transplant IEM diagnosis and acute rejection after lung transplantation.METHODS This was a retrospective cohort study of lung transplant recipients at a tertiary care center between 2007 and 2018.Patients with pre-transplant anti-reflux surgery were excluded.Manometric and reflux diagnoses were recorded from pre-transplant esophageal function testing.Time-to-event analysis using Cox proportional hazards model was applied to evaluate outcome of first episode of acute cellular rejection,defined histologically per International Society of Heart and Lung Transplantation guidelines.Subjects not meeting this endpoint were censored at time of post-transplant anti-reflux surgery,last clinic visit,or death.Fisher’s exact test for binary variables and student’s t-test for continuous variables were performed to assess for differences between groups.RESULTS Of 184 subjects(54%men,mean age:58,follow-up:443 person-years)met criteria for inclusion.Interstitial pulmonary fibrosis represented the predominant pulmonary diagnosis(41%).During the follow-up period,60 subjects(33.5%)developed acute rejection.The all-cause mortality was 16.3%.Time-to-event univariate analyses demonstrated significant association between IEM and acute rejection[hazard ratio(HR):1.984,95%CI:1.03-3.30,P=0.04],confirmed on Kaplan-Meier curve.On multivariable analysis,IEM remained independently associated with acute rejection,even after controlling for potential confounders such as the presence of acid and nonacid reflux(HR:2.20,95%CI:1.18-4.11,P=0.01).Nonacid reflux was also independently associated with acute rejection on both univariate(HR:2.16,95%CI:1.26-3.72,P=0.005)and multivariable analyses(HR:2.10,95%CI:1.21-3.64,P=0.009),adjusting for the presence of IEM.CONCLUSION Pre-transplant IEM was associated with acute rejection after transplantation,even after controlling for acid and nonacid reflux.Esophageal motility testing may be considered in lung transplant to predict outcomes. 展开更多
关键词 Ineffective esophageal motility Esophageal hypomotility Esophageal manometry Gastroesophageal reflux disease Lung transplantation Acute rejection
下载PDF
增液八珍汤对大鼠胃泌素、P物质及生长抑素含量的影响 被引量:2
3
作者 陈瑞超 佟瑶 +1 位作者 李玉刚 卜渊 《光明中医》 2015年第10期2098-2101,共4页
目的观察增液八珍汤对便秘大鼠血液及肠壁组织中胃泌素(GAS)、P物质(SP)及生长抑素(SS)含量的影响,揭示其治疗便秘的药效机理。方法将120只大鼠随机分为正常组20只,模型组100只给予甘草煎剂灌胃7天,将模型组100只大鼠随机分为模型组、... 目的观察增液八珍汤对便秘大鼠血液及肠壁组织中胃泌素(GAS)、P物质(SP)及生长抑素(SS)含量的影响,揭示其治疗便秘的药效机理。方法将120只大鼠随机分为正常组20只,模型组100只给予甘草煎剂灌胃7天,将模型组100只大鼠随机分为模型组、增液八珍汤低、中、高剂量组及西沙必利组各20只。分别灌胃给药7天后,检测各组大鼠血液及肠壁组织中GAS、SP、SS的含量。结果增液八珍汤低、中剂量组与模型组比较三项指标均有显著差异(P<0.05),高剂量组差异更明显(P<0.01);增液八珍汤低、中剂量组与西沙必利组比较三项指标均有显著差异(P<0.05),高剂量组差异更明显(P<0.01)。结论增液八珍汤可通过调节血液及肠壁组织中GAS、SP、SS的含量,达到促胃肠动力的作用。其中增液八珍汤高剂量组疗效显著,明显优于西药对照组。 展开更多
关键词 增液八珍汤 胃肠动力低下 胃泌素 P物质 生长抑素
下载PDF
益肾活血方对精子活力低下症病理模型大鼠血清睾丸活性酶的影响 被引量:4
4
作者 邢益涛 秦国政 +3 位作者 冯青 汤林 李杰 袁卓珺 《世界科学技术-中医药现代化》 CSCD 北大核心 2021年第12期4530-4536,共7页
目的观察益肾活血方对精子活力低下症病理模型大鼠精子活动力及血清睾丸活性酶的影响,初步阐述益肾活血方改善精子活动力的部分作用机制。方法将60只雄性Wistar大鼠随机分成正常组和模型组以及中药低、中、高剂量组,每组大鼠各12只。除... 目的观察益肾活血方对精子活力低下症病理模型大鼠精子活动力及血清睾丸活性酶的影响,初步阐述益肾活血方改善精子活动力的部分作用机制。方法将60只雄性Wistar大鼠随机分成正常组和模型组以及中药低、中、高剂量组,每组大鼠各12只。除正常组以外,模型组、中药各剂量组的大鼠予灌服西药雷公藤多苷片5周以造模。经成功建立精子活动低下症大鼠病理模型后,中药高、中、低各剂量组分别予益肾活血方,按5、10、15 g/kg/天调配,并进行中药灌胃5周,正常组、模型组均予普通饲养。末次给药后立即取各组大鼠的附睾尾进行精子质量相关指标检测,并采用酶联免疫法(ELISA)检测大鼠血清中顶体酶(ACE)、酸性磷酸酶(ACP)、碱性磷酸酶(AKP)、乳酸脱氢酶(LDH)、透明质酸酶(HYD)、γ-谷氨酸转肽酶(γ-GT)的浓度变化情况。结果正常组、低剂量组、中剂量组、高剂量组模型大鼠的精子总活率明显高于模型组(P<0.05);高剂量组模型大鼠的a级精子活力明显高于模型组(P<0.05);低剂量组、中剂量组、高剂量组模型大鼠的b级精子活力、a级+b级精子活力明显高于模型组(P<0.05)。正常组、低剂量组、中剂量组的ACE和AKP及LDH浓度均明显高于模型组(P<0.05),高剂量组的ACE浓度明显高于模型组(P<0.05),高剂量组的AKP和LDH浓度与模型组相比,均无显著性差异(P>0.05);正常组及治疗各剂量组的ACP浓度明显低于模型组(P<0.05);正常组以及中、高剂量组的HYD浓度高于模型组(P<0.05),低剂量组的HYD浓度与模型组相比无明显差异(P>0.05);正常组及治疗各剂量组的γ-GT浓度与模型组相比,无显著性差异(P<0.05)。结论益肾活血方显著提升实验大鼠精子的活动力,其改善病理模型大鼠精子活动力的调控机制可能是通过提升血清ACE、HYD、AKP及LDH的浓度,从而提高精子活力低下症病理模型大鼠精子的活动力。 展开更多
关键词 精子活力低下症 益肾活血法 睾丸活性酶
下载PDF
c-kit在蒽醌类泻剂所致肠动力减退发病机制中的作用 被引量:5
5
作者 霍明东 丁曙晴 +2 位作者 丁义江 江滨 张波 《江苏医药》 CAS 北大核心 2013年第11期1250-1253,共4页
目的探讨c-kit在蒽醌类泻剂所致肠动力减退发病机制中的作用。方法健康成年SPF级SD大鼠36只随机均分为模型组、模型恢复组和对照组。模型组和模型恢复组大鼠采用"大黄酸混悬液灌胃法"制作肠动力减退动物模型,对照组用等体积... 目的探讨c-kit在蒽醌类泻剂所致肠动力减退发病机制中的作用。方法健康成年SPF级SD大鼠36只随机均分为模型组、模型恢复组和对照组。模型组和模型恢复组大鼠采用"大黄酸混悬液灌胃法"制作肠动力减退动物模型,对照组用等体积生理盐水灌胃。模型组造模结束后取材,模型恢复组造模结束正常饲养30d后取材。各组大鼠处死前观察首粒黑便排出时间以检测肠道传输功能,Western blot法检测各组大鼠结肠组织中c-kit的蛋白水平。结果模型组和模型恢复组大鼠首粒黑便排出时间较对照组明显延长(P<0.01);模型组和模型恢复组结肠组织中的c-kit蛋白表达较对照组明显减弱(P<0.01)。结论蒽醌类泻剂所致肠动力减退可能与结肠组织中c-kit蛋白表达下调有关。 展开更多
关键词 蒽醌类泻剂 肠动力减退 大黄酸 C-KIT
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部